Lumature Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Lumature Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $6,578 - $8,191	-28 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $5,978 - $7,046	-27 Reduced 49.09%	28 $7,000
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $6,195 - $7,820	-35 Reduced 38.89%	55 $12,000
Q3 2021 Oct 29, 2021	SELL	$181.39 - $202.99 $4,897 - $5,480	-27 Reduced 23.08%	90 $16,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $562 - $663	3 Added 2.63%	117 $24,000
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $243,041 - $283,297	-1,174 Reduced 91.15%	114 $24,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $266,628 - $355,603	1,288 New	1,288 $304,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Lumature Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Lumature Wealth Partners, LLC with notifications on news.